British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

Barclays analyst Iain Simpson maintained a Buy rating on Haleon PLC (HLN – Research Report) today and set a price target of £4.45. The ...

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company ...

Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the ...

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.

In a report released on February 27, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a ...

Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports.

Haleon PLC HLN shares slipped 3.31% to £3.82 Thursday, on what proved to be an all-around favorable trading session for the ...

If you bought certain Robitussin products, you may be eligible to get money back as part of a $4.5 million settlement.

Haleon plc misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $25.25. Jo Russell: Good morning, everyone. Welcome to Haleon’s Full Year 2024 Q&A call. I’m Jo Russell ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...